For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

In 2025, health trends spotlight polyphenols as natural weight-loss aids and fiber for longevity. Nutritionists recommend polyphenol-rich foods and fiber boosts to improve vitality, reducing premature ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

IN Northern Ireland 65 per cent of adults are either living with overweight or obesity.  This has risen from 62 per cent in ...

KEEN to lose weight in 2025? So are almost half of our readers. While weight-loss jabs, similar to Ozempic, boomed in ...

Imagine being one of the millions of Americans in need of a hip or knee replacement due to osteoarthritis. Severe pain, ...

NHS doctor Ed Robinson says he has seen an increase in people looking for procedures to reverse two 'common concerns' ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Professor Tim Spector and his Zoe co-founder Jonathan Wolf have issued advice for those looking to change their diets in the ...